Press Release

Teva's Board Declared a Cash Dividend for Q2 2001 of Approx. 6.5�

Jerusalem, Israel, August 13, 2001 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the Board of Directors declared a cash dividend for the second quarter of 2001 of NIS 0.27 (approximately 6.5�), per ADR. The record date will be August 21, 2001, and the payment date will be September 5, 2001. Tax at a rate of 21% will be deducted at source.

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 40 pharmaceutical companies and among the largest generic pharmaceutical companies in the world. Over 80% of Teva's sales are in North America and Europe. The Company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients.

Company Contacts:

Dan Suesskind
Chief Financial Officer
Teva Pharmaceutical Industries Ltd.
(011) 972-2-589-2840
Dorit Meltzer
Director, Investor Relations
Teva Pharmaceutical Industries Ltd.
(011) 972-3-926-7554